PULMONARY NODULAR LYMPHOID HYPERPLASIA

PULMONARY NODULAR LYMPHOID HYPERPLASIA was reported 11 times

PULMONARY NODULAR LYMPHOID HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SENNOSIDES, DOCUSATE SODIUM 1 0.0250
1 POSACONAZOLE 1 0.0001
2 BENZONATATE 1 0.0001
3 ZOLEDRONIC ACID 1 0.0000
4 GEMCITABINE HYDROCHLORIDE 1 0.0000
5 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 1 0.0000
6 CISPLATIN 1 0.0000
7 RITUXIMAB 2 0.0000
8 PEMBROLIZUMAB 1 0.0000
9 SACUBITRIL AND VALSARTAN 1 0.0000
10 MORPHINE SULFATE 1 0.0000
11 PREDNISONE 4 0.0000
12 TACROLIMUS OINTMENT 0.1% 1 0.0000
13 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
14 CARBOPLATIN 1 0.0000
15 ZOLPIDEM TARTRATE 1 0.0000
16 TIOTROPIUM BROMIDE 1 0.0000
17 TACROLIMUS 1 0.0000
18 OXYCODONE HYDROCHLORIDE 1 0.0000
19 SIMVASTATIN 1 0.0000
20 LEVOTHYROXINE SODIUM 1 0.0000
21 FUROSEMIDE 1 0.0000
22 ETANERCEPT 1 0.0000